Use of magnesium sulphate during pregnancy to treat certain conditions in mothers or lower the risk of a baby being born with cerebral palsy is not associated with a higher probability of harm in newborns, a study suggests. The study, “Antenatal magnesium sulphate and adverse neonatal…
Magnesium sulfate, given to pregnant mothers in preterm labor to reduce the risk of cerebral palsy (CP) in the infant, does not give rise to other safety issues, a collaborative study between Canadian and U.K. scientists found. Earlier evidence from an analysis of multiple studies suggests that magnesium sulfate,…
Magnesium sulfate given to pregnant women at risk of preterm birth can prevent cerebral palsy and reduce the combined risk of fetal/infant death or cerebral palsy, researchers found. The study, “Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis,” was…